BioOptics Stock Watch
Markets
Stocks
Funds
Sectors
Tools
Current Price
Components
Dashboard
Latest News
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioOptics Stock Watch (CIX: BOSW)
4,410.97   -179.58 (-3.91%)
Streaming Delayed Price  /  Updated: 5:20 PM EDT, Jun 27, 2017  /  Add to My Watchlist      
View: Quote Components News
Index Value
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Price 4410.97
Volume 0
Open 4594.91
Prev. Close 4590.55
Change
-179.58
% Change
-3.91%
Today's Range 4396.78 - 4627.84
52wk Range 3977.76 - 5872.44
Performance
YTD
-429.69 (-8.88%)
1 Month
+323.11 (7.90%)
3 Month
-566.09 (-11.37%)
6 Month
-1307.94 (-22.87%)
1 Year
-134.07 (-2.95%)
Top News
More News
Mixed close as jobless claims rise
The markets closed mixed with the Dow losing 12 points to 21,397 as first time applications for unemployment benefits rose. Nasdaq added 2 points to 6,236. Read More
from MarketMinute.com Market Updates
Eloxx Pharmaceuticals Receives a US$6 Million Investment from KIP and DCS to Advance a Novel Disease-Modifying Therapy Targeting Genetic Diseases Including Cystic Fibrosis
Today, Korea Investment Partners (KIP), DSC Investments, Sevion Therapeutics, Inc. (OTCQB:SVON) and Eloxx Pharmaceuticals Ltd, a clinical stage company developing therapeutics for genetic diseases... Read More
from Business Wire News Releases
More News
More News
OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD
Updated Guideline Highlights the Limitations of Current Treatments for Secondary Hyperparathyroidism in Patients with Stage 3 or 4 Chronic Kidney Disease and Acknowledges Rayaldee as a Novel Vitamin D... Read More
from GlobeNewswire News Releases
Xenetic Biosciences Commences Patient Enrollment in Phase 2 Study Evaluating XBIO-101 in Conjunction with Progestin Therapy for the Treatment of Endometrial Cancer
Xenetic Biosciences, Inc. (NASDAQ: XBIO) (“Xenetic” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs... Read More
from Business Wire News Releases
Breakfast Technical Briefing on Biotech Stocks -- Opko Health, Pain Therapeutics, Trevena, and Dynavax Technologies
from PR Newswire
Zecotek Receives Notice of Allowance in China for New Advanced Formulation of its Worldwide Patented LFS Scintillation Crystal
from Marketwired News Releases
Syneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax Partners
Syneron Medical Ltd. (NASDAQ: ELOS) today announced that its shareholders have approved the previously announced definitive agreement under which an affiliate of funds advised by Apax Partners will... Read More
from PR Newswire
Cutera Inc: 52-Week High Recently Eclipsed (CUTR)
Cutera Inc (NASDAQ:CUTR) traded at a new 52-week high today of $25.50. So far today approximately 77,000 shares have been exchanged, as compared to an average 30-day volume of... Read More
from Comtex SmarTrend® News Briefs
How Things Look for Opko Health, Inc. in 3 Charts
from Motley Fool
BRIEF-Xenetic Biosciences commences patient enrollment in phase 2 study evaluating XBIO-101 in conjunction with Progestin therapy for the treatment of endometrial cancer
* Xenetic Biosciences commences patient enrollment in phase 2 study evaluating XBIO-101 in conjunction with Progestin therapy for the treatment of endometrial cancer Read More
from Reuters: Company News
7 Healthcare Stocks That Will Give You Chest Pains
 Read More
from InvestorPlace - Latest Headlines
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS